| Karl H Kim, MD | |
|
19250 Sw 90th Ave, Tualatin, OR 97062-7585 | |
| (503) 692-3750 | |
| (503) 691-2324 |
| Full Name | Karl H Kim |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 26 Years |
| Location | 19250 Sw 90th Ave, Tualatin, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902958671 | NPI | - | NPPES |
| 500697947 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD174473 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Willamette Falls Medical Center | Oregon city, OR | Hospital |
| Legacy Meridian Park Medical Center | Tualatin, OR | Hospital |
| Providence Newberg Medical Center | Newberg, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
The American College of Cardiology will host the ACC Latin America Conference in partnership with the Peruvian Society of Cardiology in Lima, Peru, on November 16-17, 2018, bringing together top experts to review and discuss new, relevant cardiovascular science pertinent to the region. This is the first time the conference will be held in South America.
Results from a phase III trial have shown that tecemotide is no more effective than placebo as maintenance therapy in patients with non-small-cell lung cancer.
› Verified 8 days ago
| Entity Name | Oregon Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
The American College of Cardiology will host the ACC Latin America Conference in partnership with the Peruvian Society of Cardiology in Lima, Peru, on November 16-17, 2018, bringing together top experts to review and discuss new, relevant cardiovascular science pertinent to the region. This is the first time the conference will be held in South America.
Results from a phase III trial have shown that tecemotide is no more effective than placebo as maintenance therapy in patients with non-small-cell lung cancer.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
The American College of Cardiology will host the ACC Latin America Conference in partnership with the Peruvian Society of Cardiology in Lima, Peru, on November 16-17, 2018, bringing together top experts to review and discuss new, relevant cardiovascular science pertinent to the region. This is the first time the conference will be held in South America.
Results from a phase III trial have shown that tecemotide is no more effective than placebo as maintenance therapy in patients with non-small-cell lung cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karl H Kim, MD 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Karl H Kim, MD 19250 Sw 90th Ave, Tualatin, OR 97062-7585 Ph: (503) 692-3750 |
News Archive
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
The American College of Cardiology will host the ACC Latin America Conference in partnership with the Peruvian Society of Cardiology in Lima, Peru, on November 16-17, 2018, bringing together top experts to review and discuss new, relevant cardiovascular science pertinent to the region. This is the first time the conference will be held in South America.
Results from a phase III trial have shown that tecemotide is no more effective than placebo as maintenance therapy in patients with non-small-cell lung cancer.
› Verified 8 days ago
Jaymee E Delaney, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 19260 Sw 65th Ave, Ste 270, Tualatin, OR 97062 Phone: 503-352-0770 | |
Jessica Kazue Haraga, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 19250 Sw 90th Ave, Tualatin, OR 97062 Phone: 503-692-3750 Fax: 503-691-2324 | |
Dr. Benito G Pataroque, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6485 Sw Borland Rd, Suite D, Tualatin, OR 97062 Phone: 503-692-3647 Fax: 503-691-1670 | |
Dr. Tammi Kaye Boston, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 19875 Sw 65th Ave, Suite 100, Tualatin, OR 97062 Phone: 503-692-7785 Fax: 503-885-1663 | |
Dr. William H Treuhaft, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6485 Sw Borland Rd, Suite F, Tualatin, OR 97062 Phone: 503-413-3650 Fax: 503-413-3644 | |
Dean Kyle Peterson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 19300 Sw 65th Ave, Tualatin, OR 97062 Phone: 503-413-8407 Fax: 503-413-6951 | |
Dr. Mark Leo Mckinstry, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 19875 Sw 65th Ave, Tualatin, OR 97062 Phone: 503-692-7785 Fax: 503-885-1663 |